Pre Conference Workshops (at Courtyard Marriot Prater/Messe Hotel) - CET/CEST (Cent Europe Summer, GMT+2)
Pre Conference Workshops (at Courtyard Marriot Prater/Messe Hotel) - CET/CEST (Cent Europe Summer, GMT+2)
- Emma Welbourne - Senior Research Associate - RNA Analytics, University of Sheffield
- Silvia Lecci, PhD - Team Leader, CPI
- Lorenzo De Benedictis, MA - Head of Business Unit Pharma | Medical, 3CON Anlagenbau GmbH
This talk will discuss our ongoing work developing a biocatalyst toolbox for mRNA manufacture, comprising functionally-diverse RNA polymerases and cell factory-based platforms. This toolkit of biocatalysts with varied and specialised bioproduction phenotypes facilitates design and troubleshooting of molecule-specific manufacturing processes to optimise yield and quality of next-generation mRNA products.
- Adam Brown, Ph.D. - Associate Professor of Biopharmaceutical Engineering; CTO, University of Sheffield
- June Kim - CMC Lead, CEPI
- Mark Duerkop - Chief Executive Officer, Novasign
- Harris Makatsoris - Academics Professor of Sustainable Manufacturing Systems, King's College London
- Veronique Chotteau, PhD - Professor in mammalian-based bioprocessing, KTH - Royal Institute of Technology
- Mark Duerkop - Chief Executive Officer, Novasign
- Sebastian Thuermann - Product Manager MCC, Tosoh Bioscience GmbH
- Joseph Zeguer - Senior Scientist - Synthetic and Mammalian Upstream, CPI
- Alois Jungbauer - Professor, Dept. of Biotechnology, University of Natural Resources and Applied Life Sciences
- Dominik Wolfsberger - Bioprocess Sales Specialist, Eppendorf
•Introduction to Tech Transfer
•Definition of TT
•Tech transfer: a Project with Challenges
• Session 1 : Formal Aspects
•Regulatory concerns ; product comparability
•Tech Transfer Procedure, Protocol & Report
- Thomas Chattaway - Senior Life Science Consultant, Independent Consultant
•Session 2: Tools for Tech Transfer
•Transfer of Information
•Dealing with Scale up and changes
•Analytical Transfer
- Thomas Chattaway - Senior Life Science Consultant, Independent Consultant
- James Dean Vogel - Founder and Director , The BioProcess Institute
- Alois Jungbauer - Professor, Dept. of Biotechnology, University of Natural Resources and Applied Life Sciences
- Paula Martinelli - Life Sciences Product Manager, NewAge Industries, Inc.
- Beth Albuck - Senior Sales Manager, NewAge Industries, Inc.
- James Dean Vogel - Founder and Director , The BioProcess Institute
- Alois Jungbauer - Professor, Dept. of Biotechnology, University of Natural Resources and Applied Life Sciences
- Beth Albuck - Senior Sales Manager, NewAge Industries, Inc.
- Paula Martinelli - Life Sciences Product Manager, NewAge Industries, Inc.
We invite you to join us for a comprehensive exploration of the microbial market and technology, an area characterized by its diversity and the complexity of molecule formats. This field demands expertise and experience in development and manufacturing, and we at Boehringer Ingelheim are eager to share our insights and demonstrate how we can cater to your needs.
Join us for an enlightening on-site tour at our Regional Center in the heart of Austria’s capital Vienna, where we will showcase our capabilities covering the entire value chain of microbial derived biologics from the early stages of development through to the commercial manufacturing.
The three-hour tour also includes an opportunity to interact with our technology experts and senior management at Boehringer Ingelheim, fostering a platform for scientific dialogue and collaboration.
We look forward to welcoming you and fostering a fruitful exchange of ideas.
Registration is free but please note that all registrations are subject to approval by Boehringer Ingelheim. A bus will be available for roundtrip transportation from the Messe Wien Congress Centre. The whole event, inclusive of travel time, is expected to last around 4 hours.
- Key takeaways from the day's talks: lessons from other modalities, continuous manufacturing, analytical methods, LNP manufacturing, GMP considerations.
- The crucial role of academia in transforming research and initiating innovation in the industry.
- Emerging challenges and opportunities in RNA therapy development and manufacturing:
- Expanding applications.
- Addressing regulatory hurdles and harmonization.
- Industry & academia collaboration.
- Adam Brown, Ph.D. - Associate Professor of Biopharmaceutical Engineering; CTO, University of Sheffield
- Emma Welbourne - Senior Research Associate - RNA Analytics, University of Sheffield
- Kirill Afonin, PhD - Vice President | Professor, International Society of RNA Nanotechnology and Nanomedicine (ISRNN) | UNC Charlotte
- Manuel Carrondo - Vice-President, Instituto de Biologia Experimental e Tecnológica
- Michael Olma - Supervisor GMP Advanced Analytics, MSD
- Maria Papathanasiou - Senior Lecturer (Associate Professor), Imperial College London
•Session 3 : Complexities of Tech Transfer
•Complexity and Risk Factors
•The importance of communication
•Optimising the transfer programme
Key Take-Aways:
- What are hybrid models and how do they compare to standard DOE tools
- What are practical benefits of hybrid models for industrial bioprocess development
- Experience hybrid model-derived process design yourself in a hands-on use case
Preparation:
- Please bring your laptop
- After registration you will be provided with a personalized account to access the software
Target group:
- Process development/MSAT professionals interested in smart digital solutions support their daily work
- Experts in DOE software interested to explore the potential of AI tools for bioprocessing
- No model or coding experience is required upfront
Description;
The workshop will start with a short introduction of hybrid modeling based on some
industrial use cases. Thereafter, the participants will be introduced into a use case
where they can analyze bioprocess data with the goal to optimize a bioprocess based
on a hybrid model. All teams with be supported in that interactive experience by
experienced modeling experts and at the end the winning team will be rewarded with
Swiss chocolates.
We invite you to join us for a comprehensive exploration of the microbial market and technology, an area characterized by its diversity and the complexity of molecule formats. This field demands expertise and experience in development and manufacturing, and we at Boehringer Ingelheim are eager to share our insights and demonstrate how we can cater to your needs.
Join us for an enlightening on-site tour at our Regional Center in the heart of Austria’s capital Vienna, where we will showcase our capabilities covering the entire value chain of microbial derived biologics from the early stages of development through to the commercial manufacturing.
The three-hour tour also includes an opportunity to interact with our technology experts and senior management at Boehringer Ingelheim, fostering a platform for scientific dialogue and collaboration.
We look forward to welcoming you and fostering a fruitful exchange of ideas.
Registration is free but please note that all registrations are subject to approval by Boehringer Ingelheim. A bus will be available for roundtrip transportation from the Messe Wien Congress Centre. The whole event, inclusive of travel time, is expected to last around 4 hours.
- Matthias Hecht - Post Doc Downstream Bioprocess Development, Boehringer Ingelheim
- Manuel Carrondo - Vice-President, Instituto de Biologia Experimental e Tecnológica
•Workshop: Tech Transfer in the life -cycle
Key Take-Aways:
- What are hybrid models and how do they compare to standard DOE tools
- What are practical benefits of hybrid models for industrial bioprocess development
- Experience hybrid model-derived process design yourself in a hands-on use case
Preparation:
- Please bring your laptop
- After registration you will be provided with a personalized account to access the software
Target group:
- Process development/MSAT professionals interested in smart digital solutions support their daily work
- Experts in DOE software interested to explore the potential of AI tools for bioprocessing
- No model or coding experience is required upfront
Description;
The workshop will start with a short introduction of hybrid modeling based on some
industrial use cases. Thereafter, the participants will be introduced into a use case
where they can analyze bioprocess data with the goal to optimize a bioprocess based
on a hybrid model. All teams with be supported in that interactive experience by
experienced modeling experts and at the end the winning team will be rewarded with
Swiss chocolates.
- Michael Sokolov - COO, DataHow